Of note, TLR2 blocking antibodies exert a double role by acting not only on cancer cells but also on host immune cells, reversing the tumor cell-induced immunosuppressive microenvironment and restoring the activity of anti-cancer cells such as cytotoxic T cells and M1 macrophages [131]. The gene discussed is TLR2; the disease is neoplasm.